|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 7/00 | (2018.01) |
| A61K 38/17 | (2006.01) | ||
| C12N 15/62 | (2006.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| C07K 14/41 | (2006.01) | ||
| A61P 7/06 | (2018.01) | ||
| A61K 38/00 | (2013.01) | ||
| G01N 33/5088 | (2013.01) | ||
| C07K2319/31 | (2013.01) | ||
| C07K2319/30 | (2013.01) | ||
| G01N2500/04 | (2013.01) | ||
| C07K 14/71 | (2013.01) | ||
| A61K 38/1796 | (2013.01) | ||
| G01N 33/80 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3320911 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17182870.0 |
| Date of filing the European patent application | 2007-12-18 | |
| (97) | Date of publication of the European application | 2018-05-16 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 875682 P | 2006-12-18 | US |
| (72) |
SHERMAN, Matthew L. , US
|
| (73) |
Acceleron Pharma Inc. ,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS |
| ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS |